Zhang Shun, Wan Zhengpeng, Kamm Roger D
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Lab Chip. 2021 Feb 9;21(3):473-488. doi: 10.1039/d0lc01186j.
Human organoids, self-organized and differentiated from homogenous pluripotent stem cells (PSC), replicate the key structural and functional characteristics of their in vivo counterparts. Despite the rapid advancement of organoid technology and its diverse applications, major limitations in achieving truly in vivo like functionality have been the lack of matured structural organization and constraints on tissue size, both of which are direct consequences of lacking a functional vasculature. In the absence of perfusable vessels, a core region within organoids quickly becomes necrotic during development due to increased metabolic demands that cannot be met by diffusion alone. Thus, incorporating functional vasculature in organoid models is indispensable for their growth in excess of several hundred microns and maturaturation beyond the embryonic and fetal phase. Here, we review recent advancements in vascularizing organoids and engineering in vitro capillary beds, and further explore strategies to integrate them on a microfluidic based platform, aiming for establishing perfused vasculature throughout organoids in vitro.
人类类器官由同质多能干细胞(PSC)自组织分化而成,复制了其体内对应物的关键结构和功能特征。尽管类器官技术取得了快速进展并有着多样的应用,但在实现真正的体内功能方面仍存在重大限制,即缺乏成熟的结构组织以及对组织大小的限制,这两者都是缺乏功能性脉管系统的直接后果。在没有可灌注血管的情况下,类器官内部的核心区域在发育过程中会因代谢需求增加而迅速坏死,仅靠扩散无法满足这些需求。因此,在类器官模型中纳入功能性脉管系统对于其超过数百微米的生长以及超越胚胎和胎儿阶段的成熟至关重要。在这里,我们回顾了类器官血管化和体外毛细血管床工程的最新进展,并进一步探索将它们整合到基于微流控的平台上的策略,旨在在体外建立贯穿类器官的灌注脉管系统。